The US Food and Drug Administration (FDA) is requesting feedback on availability for medical use of cannabis and derivatives of the plant, which are...
Elixinol Global's Australian subsidiary has had a name change and a key
element of its medical cannabis plans in the country has been secured.
Elixinol...
Bod Australia Limited (ASX:BDA) announced yesterday its cannabidiol based cannabis extract will be used in a Post-Traumatic Stress Disorder (PTSD) trial.
The extract, MediCabilis 5%...
The latest stats from the Oklahoma Medical Marijuana Authority (OMMA) indicate the
program is doing quite well, particularly for such a new initiative.
OMMA is...